Harmony Biosciences Holdings, Inc. (HRMY) NASDAQ
31.41
-0.3986(-1.25%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Harmony Biosciences Holdings, Inc.
Address
630 West Germantown Pike
Plymouth Meeting, PA 19462
United States of America (the)
Phone
484 539 9800
Sector
Healthcare
Industry
Biotechnology
Employees
268
First IPO Date
August 19, 2020
Key Executives
| Name | Title | Pay | Year Born |
| Jeffrey Dayno | President, Chief Executive Officer & Director | 1.32M | 1957 |
| Peter Anastasiou | Chief Operating Officer | 58,250 | 1970 |
| Jeffrey S. Aronin | Founder & Non-Executive Chairman | 77,500 | 1968 |
| Andrew Serafin | Executive Vice President & Chief Strategy Officer | 681,398 | 1975 |
| Kumar Budur | Executive Vice President and Chief Medical & Scientific Officer | 919,062 | 1971 |
| Adam Zaeske | Executive Vice President & Chief Commercial Officer | 946,228 | 1973 |
| Sandip S. Kapadia | Executive Vice President, Chief Administrative Officer & Chief Financial Officer | 1.06M | 1970 |
| Glenn Reicin | Chief Financial Officer | 0 | 1965 |
| Christian Ulrich | Executive VP, General Counsel & Corporate Secretary | 0 | N/A |
| Brennan Doyle | Vice President & Head of Investor Relations | 0 | N/A |
| Audrey Murphy | Chief Human Resources Officer | 0 | N/A |
| Cate McCanless | Senior Vice President & Chief Corporate Affairs Officer | 0 | N/A |
| Tricia Glover | Chief Compliance Officer | 0 | N/A |
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is based in Plymouth Meeting, Pennsylvania.
